The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Continuation and Maintenance Use of Antidepressants in Recurrent Depression
Abstract
Background: Maintenance antidepressant (AD) medication is the most commonly used preventive strategy in a highly recurrent disease, i.e. depression. Little is known about the discontinuation of maintenance AD use and the association with recurrence in daily clinical practice. The purpose was to examine the discontinuation rate of maintenance AD in daily clinical practice in recurrently depressed patients and the associated risk of recurrence. Methods: Prospectively AD maintenance medication and recurrence were examined in 172 euthymic patients with recurrent depression. AD user profiles before recurrence (nonusers, intermittent users, continuous users) were examined and related to recurrence over a 2-year follow-up period. Results: Less than half of the patients (42%) used AD continuously. Taking into account the minimal required adequate used dosage (≧20 mg fluoxetine equivalent), only 26% of the patients used AD as recommended by international guidelines. Despite continuous use of AD, 60.4% relapsed in 2 years. This relapse rate was comparable to the rate of the intermittent users (63.6%). In patients who stopped taking AD after remission and who received additional preventive CT, the recurrence rates were significantly lower than in non-AD-using patients treated with usual care (8 vs. 46%). Conclusions: The majority of recurrently depressed patients treated with AD discontinue maintenance AD therapy in daily primary and secondary clinical practice. AD seems to offer poor protection against relapse in this patient group. Patients who stopped using AD experienced less relapse, especially if they were treated with preventive CT. Alternative maintenance treatments (including preventive cognitive therapy after discontinuation of AD) should be studied in recurrently depressed patients with intermittent good remission, not only in secondary but also in primary care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when comparing antidepressant maintenance treatment to tapering with psychological support, long-term relapse rates for depression are comparable34–36 or in some cases lower for patients receiving psychological therapy.37 38”
From Helping people discontinue long-term antidepressants: views of health professionals in UK primary care (2019) · cites this paper as [36]
In the citing paper
“On the other hand, possibly as a consequence of our optimisation of mADM in the control condition, the adherence rate with mADM seems to be rather high compared with some other studies (Bockting et al., 2008;Kuyken et al., 2008;Olfson et al., 2006).”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Bockting et al., 2008
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Ma, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Publication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997) · American Psychiatric Press eBooks · Cited by 983
Distributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“Currently, maintenance antidepressant (AD) medication is the most commonly advised preventive strategy [”
BackgroundTreatment of Depression by Drugs and Psychotherapy
KLERMAN, G. L., DIMASCIO, A., WEISSMAN, M., PRUSOFF, B., & PAYKEL, E. S. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.2.186 · Cited by 500
Prevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Six-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1872 · Cited by 392
Continuity of Antidepressant Treatment for Adults With Depression in the United States
Ballenger, J. C. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70480-8 · Cited by 313
Six-Year Outcome for Cognitive Behavioral Treatment of Residual Symptoms in Major Depression
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1443 · Cited by 299
Sertraline Treatment of Pathological Gambling: A Pilot Study
Saiz-Ruiz, J., Blanco, C., Ibáñez, A., Masramon, X., Gómez, M. M., Madrigal, M., & Díez, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0104 · Cited by 293
Bockting, C. L. H., DELTA Study Group, Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.4.647 · Cited by 249
Self-citationCan long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204
Blackburn, I.-M., & Moore, R. G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.4.328 · Cited by 179
Compliance during treatment with antidepressants
Demyttenaere, K. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)00095-x · Cited by 166
KENNEDY, N., ABBOTT, R., & PAYKEL, E. S. (2003) · Psychological Medicine · doi:10.1017/s003329170300744x · Cited by 165
Discontinuing antidepressant treatment in major depression.
Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809003578 · Cited by 145
Glen, A. I. M., Johnson, A. L., & Shepherd, M. (1984) · Psychological Medicine · doi:10.1017/s0033291700003068 · Cited by 139
Treatment of depression--newer pharmacotherapies.
Mulrow, C. D., Williams, J. W., Trivedi, M. H., Chiquette, E., Aguilar, C., Cornell, J. E., Badgett, R. G., Noël, P. H., Lawrence, V. A., Lee, S., et al. (1999) · PubMed Central · Cited by 124
The Road to Recovery from Depression – Don’t Drive Today with Yesterday’s Map
Fava, G. A., Tomba, E., & Grandi, S. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000104701 · Cited by 120
Depression: Treatment compliance in general practice
Johnson, D. A. W. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00751.x · Cited by 114
Continuity Is the Main Challenge in Treating Major Depressive Disorder in Psychiatric Care
Melartin, T. K., Rytsälä, H. J., Leskelä, U. S., Lestelä-Mielonen, P. S., Sokero, T. P., & Isometsä, E. T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0210 · Cited by 111
Sequential Treatment of Mood and Anxiety Disorders
Fava, G. A., Ruini, C., & Rafanelli, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1108 · Cited by 103
Continuation Therapy with Amitriptyline in Depression
Coppen, A. J., Ghose, K., Montgomery, S., Rao, V. A. R., Bailey, J., & Jørgensen, A. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.133.1.28 · Cited by 103
(2005) · PubMed · Cited by 93
Bockting, C., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., & Schene, A. H. (2006) · PubMed · Cited by 84
Self-citationEvidence Report: Treatment of Depression - Newer Pharmacotherapies
Agency for Health Care Policy and Research (AHCPR) (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-991098 · Cited by 84
Adams, C. E. (2004) · Psychiatric Bulletin · doi:10.1192/pb.28.9.351 · Cited by 83
MUSHROOM POISONING AND FORCED DIURESIS
Vesconi, S., Langer, M., & Costantino, D. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90193-2 · Cited by 76
Do Antidepressant and Antianxiety Drugs Increase Chronicity in Affective Disorders?
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288880 · Cited by 73
Phenelzine for chronic depression: a study of continuation treatment.
Harrison, W. M., Rabkin, J. G., Stewart, J. W., McGrath, P. J., TRICAMO, E., & Quitkin, F. M. (1986) · PubMed · Cited by 72
Treatment of Recurrent Depression: A Sequential Psychotherapeutic and Psychopharmacological Approach
Fava, G. A., Ruini, C., & Sonino, N. (2003) · CNS Drugs · doi:10.2165/00023210-200317150-00005 · Cited by 69
Claxton, A. J., Li, Z., & McKendrick, J. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.2.163 · Cited by 68 · cited 1×
“Despite the continuous use of AD (before recurrence), 60.4p relapsed in 2 years. This recurrence rate was comparable to the rate of the intermittent users (63.6p). Also the number of times a patient experienced a recurrence as well as the overall severity and the duration of the recurrences were comparable in the 2 gr…”
ResultMaintenance therapy with amitriptyline: a controlled trial
Stein, M. K., Rickels, K., & Weise, C. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.3.370 · Cited by 65
Recurrence of depression after discontinuation of long-term amitriptyline treatment
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.3.325 · Cited by 62
Dawson, R., Lavori, P. W., Coryell, W. H., Endicott, J., & Keller, M. B. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00181-x · Cited by 56
Assay Sensitivity, Failed Clinical Trials, and the Conduct of Science
Otto, M. W., & Nierenberg, A. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000064813 · Cited by 42
Unipolar depression in the elderly
Cook, B. L., Helms, P. M., Smith, R. E., & Tsai, M. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90031-5 · Cited by 36
Use of Phenelzine in Continuation Therapy
Davidson, J. R. T., & Raft, D. D. (2008) · Neuropsychobiology · doi:10.1159/000118076 · Cited by 34
Holding On: Depression, Sensitization by Antidepressant Drugs, and the Prodigal Experts
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288992 · Cited by 33
CONTINUATION THERAPY WITH TRICYCLIC ANTIDEPRESSANTS IN DEPRESSIVE ILLNESS
Mindham, R. H. S., Howland, C., & Shepherd, M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92214-3 · Cited by 33
Risks and Implications of Interrupting Maintenance Psychotropic Drug Therapy
Baldessarini, R. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288950 · Cited by 30
Patten, S. B. (2004) · Population Health Metrics · doi:10.1186/1478-7954-2-9 · Cited by 28
Physical Disorder Among Day Hospital Patients
Burke, A. W. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.133.1.22 · Cited by 25
Treatment of Depressive Disorders with and without Medication - A Naturalistic Study
Hasler, G., Schnyder, U., Klaghofer, R., & Angst, J. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-36387 · Cited by 9
Research works printed but not linked: 7
- 10.1176%2Fappi.ajp.163.1.101 · DOI · Paper page
- 10.4088%2FJCP.v67n0508 · DOI
- 10.1176%2Fappi.ajp.163.11.1905 · doi:10.1176/appi.ajp.163.11.1905 · Paper page
- 10.1159%2F000288931 · DOI · Paper page
- 10.4088%2FJCP.v66n0112 · DOI · Paper page
- 10.1176%2Fappi.ajp.161.10.1872 · DOI
- 10.1037%2F%2F0022-006X.68.4.615 · doi:10.1037//0022-006x.68.4.615 · Paper page
Cited by
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.168 · Cited by 429
Increasing Psychological Well‐Being and Resilience by Psychotherapeutic Methods
Fava, G. A., & Tomba, E. (2009) · Journal of Personality · doi:10.1111/j.1467-6494.2009.00604.x · Cited by 362
Efficacy and effectiveness of antidepressants: current status of research
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000318293 · Cited by 347
Goldwater, D. S., Pavlides, C., Hunter, R. G., Bloss, E. B., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.053 · Cited by 333
“Nevertheless, there is an almost 50% chance of mood disorder relapse following disease remission (Bockting et al., 2008, Kornstein, 2008).”
BackgroundBockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.003 · Cited by 295
Self-citation
Metadata
- Authors
- Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Leiden University (NL)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2007-12-14
- Volume
- 77
- Issue
- 1
- Pages
- 17-26
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2012949854
- Cited by
- 121
- References
- 53
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 4 · 2015: 10 · 2014: 3 · 2013: 4 · 2012: 9
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- recurrent depression, antidepressant discontinuation, relapse prevention, relapse risk, cognitive therapy, primary care, secondary care
- MeSH terms
- Adult, Antidepressive Agents, Combined Modality Therapy, Depressive Disorder, Major, Major Depressive Disorder, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Long-Term Care, Male, Middle Aged, Patient Compliance, Patient Dropouts, Personality Disorders, Prospective Studies, Cohort Studies, Comorbidity, Cognitive Behavioral Therapy, Treatment Outcome, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.